-
1.发明公开公开(公告)号：US20240046457A1
公开(公告)日：2024-02-08
申请号：US18232246
申请日：2023-08-09
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Ulf Hedin , Ljubica Matic , Matthew Phillips
CPC classification number: G06T7/0012 , A61B5/055 , G16B5/00 , G16C20/30 , G16H20/00 , G06T2207/10088 , G06T2207/30101
Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a combination of any two or more therapies selected from a lipid-lowering therapy, an anti-inflammatory therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
-
2.发明公开公开(公告)号：US20240006066A1
公开(公告)日：2024-01-04
申请号：US18243138
申请日：2023-09-07
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Ulf Hedin , Ljubica Matic , Matthew Phillips
Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a lipid-lowering therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
-
公开(公告)号：US12125572B2
公开(公告)日：2024-10-22
申请号：US18232231
申请日：2023-08-09
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Ulf Hedin , Ljubica Matic , Matthew Phillips
Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of an anti-inflammatory therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
-
公开(公告)号：US20240021306A1
公开(公告)日：2024-01-18
申请号：US18242413
申请日：2023-09-05
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Ulf Hedin , Ljubica Matic , Matthew Phillips
Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a lipid-lowering therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
-
公开(公告)号：US20230420131A1
公开(公告)日：2023-12-28
申请号：US18243143
申请日：2023-09-07
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Ulf Hedin , Ljubica Matic , Matthew Phillips
Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a lipid-lowering therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
-
Patent Agency Ranking
公开(公告)号：US11791027B2
公开(公告)日：2023-10-17
申请号：US17838146
申请日：2022-06-10
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Ulf Hedin , Ljubica Matic , Matthew Phillips
Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of an anti-inflammatory therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
-
公开(公告)号：US20230290433A1
公开(公告)日：2023-09-14
申请号：US17693229
申请日：2022-03-11
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Ljubica Matic , Ulf Hedin
IPC: G16B5/20
CPC classification number: G16B5/20
Abstract: Atherosclerotic plaque phenotyping by image data analysis, e.g., using conventional computed tomography angiography (CTA) or other imaging modalities can elucidate the molecular signature of atherosclerotic lesions on a per-patient basis.
-
8.发明公开公开(公告)号：US20240087742A1
公开(公告)日：2024-03-14
申请号：US18243132
申请日：2023-09-07
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Ulf Hedin , Ljubica Matic , Matthew Phillips
Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a lipid-lowering therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
-
9.发明授权公开(公告)号：US11887713B2
公开(公告)日：2024-01-30
申请号：US17838147
申请日：2022-06-10
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Ulf Hedin , Ljubica Matic , Matthew Phillips
Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of an anti-diabetic therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
-
10.发明授权公开(公告)号：US11869186B2
公开(公告)日：2024-01-09
申请号：US17838140
申请日：2022-06-10
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Ulf Hedin , Ljubica Matic , Matthew Phillips
CPC classification number: G06T7/0012 , A61B5/055 , G16B5/00 , G16C20/30 , G16H20/00 , G06T2207/10088 , G06T2207/30101
Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a combination of any two or more therapies selected from a lipid-lowering therapy, an anti-inflammatory therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
-
-
-
-
-
-
-
-
-
Search Results
28
records
(took 0.017 seconds)
